Therefore, this study enrolled a total of 266 patients with AIS, including 101 with recurrent ischemic stroke and 165 with first-ever ischemic stroke, to evaluate the relationship between sLOX-1 levels and the prediction of functional outcomes in patients with AIS. Here, OLR1 is linked to androgen insensitivity syndrome.